MedTrace Logo

Goal Directed Fluid Therapy

NCT00860704 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-10-18

No results posted yet for this study

Summary

Intraoperative fluid demand will be monitored by Esophageal Doppler in lean and obese patients.

Conditions

  • Goal Directed Fluid Therapy

Interventions

DRUG

fluidotherapy with ringer-lactate

a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Andrea Holzer, MD · Medical University Vienna, Department of Anesthesiology and General Intensive Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860704 on ClinicalTrials.gov